GFAP and neoplasm: Even at early time points, AAV6 predominantly transduces astrocytes identified as GFAP + RFP− (70–80% EGFP + cells), with limited EGFP expression observed in RFP + tumor cells (< 15%) (Extended Data Fig. 1g, Fig. 4a).